منابع مشابه
Interferon beta-1a–induced morphea
IL-4: Interleukin 4 IFN-b: Interferon beta IFN-b1a: Interferon beta-1a MS: Multiple sclerosis SSc: Systemic sclerosis Th2: T helper 2 INTRODUCTION Interferon beta-1a (IFN-b1a) is a cytokine therapy used in the treatment of relapsing-remitting multiple sclerosis. The most common adverse injection site reactions include local erythema, pain, and induration. Other less frequently encountered react...
متن کاملDeep morphea induced by interferon-β1b injection
IFN: interferon ISR: injection site reaction MS: multiple sclerosis INTRODUCTION Morphea, also known as localized scleroderma, is an uncommon fibrosing condition of the skin and underlying tissue. Although the etiology is unknown, morphea is considered an autoimmune condition in which genetic and environmental factors contribute to disease onset. Although most cases are spontaneous, several inc...
متن کامل[Vitiligo and morphea: autoimmune cutaneous side effects of interferon treatment].
The interferons comprise a family of proteins belonging to the cytokines involved in regulation of the immune response. They exert antiviral, antineoplastic, antiangiogenic, and immunomodulating effects. High-dose interferon alfa is the only treatment to date that has been shown to improve disease-free survival in patients with advanced melanoma in randomized prospective trials. Its side effect...
متن کاملVitiligo and Morphea: Autoimmune Cutaneous Side Effects of Interferon Treatment
The interferons comprise a family of proteins belonging to the cytokines involved in regulation of the immune response. They exert antiviral, antineoplastic, antiangiogenic, and immunomodulating effects. High-dose interferon alfa is the only treatment to date that has been shown to improve disease-free survival in patients with advanced melanoma in randomized prospective trials. Its side effect...
متن کاملInterferon beta babies.
Many women with multiple sclerosis (MS) ask about the risks of pregnancy before starting (or while on) disease-modifying therapies (DMTs). At least twothirds of patients with MS are women, and the majority are in their childbearing years at the time of clinical onset and diagnosis. DMTs taken during pregnancy could have direct or indirect toxicity (through immunomodulating properties) on pregna...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAAD Case Reports
سال: 2015
ISSN: 2352-5126
DOI: 10.1016/j.jdcr.2014.10.002